{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:53:02Z","timestamp":1785498782982,"version":"3.56.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ijcard.2019.06.073","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T19:38:48Z","timestamp":1562269128000},"page":"186-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"special_numbering":"C","title":["Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy"],"prefix":"10.1016","volume":"299","author":[{"given":"Giuseppe","family":"Limongelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Monda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Tramonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Gragnano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Masarone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Frisso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Gravino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Ammendola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Salerno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Caiazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagiovanna","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry Mark","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pacileo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"39","key":"10.1016\/j.ijcard.2019.06.073_bb0005","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Authors\/Task Force members","year":"2014","journal-title":"Eur. Heart J."},{"issue":"24","key":"10.1016\/j.ijcard.2019.06.073_bb0010","first-page":"e783","volume":"124","author":"Gersh","year":"2011","journal-title":"American Heart Association Task Force on Practice Guidelines. Circulation."},{"issue":"7","key":"10.1016\/j.ijcard.2019.06.073_bb0015","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.ijcard.2019.06.073_bb0020","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/eurheartj\/ehx819","article-title":"EORP Cardiomyopathy Registry Investigators. The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies","volume":"39","author":"Charron","year":"2018","journal-title":"Eur. Heart J."},{"issue":"24","key":"10.1016\/j.ijcard.2019.06.073_bb0025","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1136\/heartjnl-2013-303939","article-title":"A systematic review and meta-analysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations","volume":"99","author":"Lopes","year":"2013","journal-title":"Heart."},{"issue":"1","key":"10.1016\/j.ijcard.2019.06.073_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2459\/JCM.0000000000000589","article-title":"Contemporary genetic testing in inherited cardiac disease: tools, ethical issues, and clinical applications","volume":"19","author":"Girolami","year":"2018","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"issue":"3","key":"10.1016\/j.ijcard.2019.06.073_bb0035","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/CIRCGENETICS.111.960468","article-title":"Prevalence of sequence variants in the RAS-mitogen activated protein kinase signaling pathway in pre-adolescent children with hypertrophic cardiomyopathy","volume":"5","author":"Kaski","year":"2012","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.ijcard.2019.06.073_bb0040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijcard.2017.07.068","article-title":"Cardiac defects, morbidity and mortality in patients affected by RASopathies. CARNET study results","volume":"245","author":"Calcagni","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2019.06.073_bb0045","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/hrt.2005.063818","article-title":"The heart in Anderson-Fabry disease and other lysosomal storage disorders","volume":"93","author":"Linhart","year":"2007","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.ijcard.2019.06.073_bb0050","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/heartjnl-2015-308193","article-title":"Mitochondrial disease and the heart","volume":"103","author":"Limongelli","year":"2017","journal-title":"Heart"},{"issue":"12","key":"10.1016\/j.ijcard.2019.06.073_bb0055","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2459\/JCM.0b013e3283641c69","article-title":"Skeletal muscle involvement in cardiomyopathies","volume":"14","author":"Limongelli","year":"2013","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"issue":"6","key":"10.1016\/j.ijcard.2019.06.073_bb0060","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003815","article-title":"Design and rationale of the phase 3 ATTR-ACT clinical trial (Tafamidis in transthyretin cardiomyopathy clinical trial)","volume":"10","author":"Maurer","year":"2017","journal-title":"Circ. Heart Fail."},{"issue":"19","key":"10.1016\/j.ijcard.2019.06.073_bb0065","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehs397","article-title":"Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Rapezzi","year":"2013","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ijcard.2019.06.073_bb0070","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4103\/jcecho.jcecho_2_18","article-title":"Diagnostic clues for the diagnosis of nonsarcomeric hypertrophic cardiomyopathy (phenocopies): amyloidosis, fabry disease, and mitochondrial disease","volume":"28","author":"Limongelli","year":"2018","journal-title":"J. Cardiovasc. Echogr."},{"issue":"4","key":"10.1016\/j.ijcard.2019.06.073_bb0075","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.hfc.2010.05.004","article-title":"Hypertrophic cardiomyopathy in childhood","volume":"6","author":"Colan","year":"2010","journal-title":"Heart Fail. Clin."},{"key":"10.1016\/j.ijcard.2019.06.073_bb0080","series-title":"Giuseppe","first-page":"39","author":"Limongelli","year":"2011"},{"issue":"1","key":"10.1016\/j.ijcard.2019.06.073_bb0085","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1399-0004.2009.01190.x","article-title":"A child cohort study from southern Italy enlarges the genetic spectrum of hypertrophic cardiomyopathy","volume":"76","author":"Frisso","year":"2009","journal-title":"Clin. Genet."},{"issue":"1","key":"10.1016\/j.ijcard.2019.06.073_bb0090","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jmoldx.2013.07.008","article-title":"DNA sequence capture and next-generation sequencing for the molecular diagnosis of genetic cardiomyopathies","volume":"16","author":"D'Argenio","year":"2014","journal-title":"J. Mol. Diagn."},{"issue":"4","key":"10.1016\/j.ijcard.2019.06.073_bb0095","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/heartjnl-2016-310138","article-title":"Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy","volume":"103","author":"Rosmini","year":"2017","journal-title":"Heart."},{"issue":"4","key":"10.1016\/j.ijcard.2019.06.073_bb0100","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1542\/peds.2006-0163","article-title":"Factors associated with establishing a causal diagnosis for children with cardiomyopathy","volume":"118","author":"Cox","year":"2006","journal-title":"Pediatrics."},{"issue":"2","key":"10.1016\/j.ijcard.2019.06.073_bb0105","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/eurheartj\/ehv497","article-title":"European Cardiomyopathy Pilot Registry: EURObservational Research Programme of the European Society of Cardiology","volume":"37","author":"Elliott","year":"2016","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.ijcard.2019.06.073_bb0110","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/CIRCULATIONAHA.106.621185","article-title":"Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the pediatric Cardiomyopathy Registry","volume":"115","author":"Colan","year":"2007","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2019.06.073_bb0115","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijcard.2018.07.091","article-title":"Cardiac outcome in classic infantile Pompe disease after 13 years of treatment with recombinant human acid alpha-glucosidase","volume":"269","author":"Van Capelle","year":"2018","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2019.06.073_bb0120","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ijcard.2019.06.073_bb0125","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ymgme.2018.04.007","article-title":"The effect of enzyme replacement therapy on clinical outcomes in paediatric patients with Fabry disease - a systematic literature review by a European panel of experts","volume":"126","author":"Spada","year":"2019","journal-title":"Mol. Genet. Metab."},{"issue":"11","key":"10.1016\/j.ijcard.2019.06.073_bb0130","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid Cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2019.06.073_bb0135","doi-asserted-by":"crossref","first-page":"xi","DOI":"10.1016\/j.hfc.2018.01.003","article-title":"On the road from gene to therapy in inherited cardiomyopathies","volume":"14","author":"Limongelli","year":"2018","journal-title":"Heart Fail. Clin."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319308836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319308836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:44:09Z","timestamp":1759092249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527319308836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":27,"alternative-id":["S0167527319308836"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.06.073","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.06.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}